Order Article Reprints

Tran CG, Borbon LC, Mudd JL, Abusada E, AghaAmiri S, Ghosh SC, Vargas SH, Li G, Beyer GV, McDonough M, et al. Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy. Cancers. 2022; 14(8):1910. https://doi.org/10.3390/cancers14081910

Tran, Catherine G., Luis C. Borbon, Jacqueline L. Mudd, Ellen Abusada, Solmaz AghaAmiri, Sukhen C. Ghosh, Servando Hernandez Vargas, Guiying Li, Gabriella V. Beyer, Mary McDonough, and et al. 2022. "Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy" Cancers 14, no. 8: 1910. https://doi.org/10.3390/cancers14081910

Tran, C. G., Borbon, L. C., Mudd, J. L., Abusada, E., AghaAmiri, S., Ghosh, S. C., Vargas, S. H., Li, G., Beyer, G. V., McDonough, M., Li, R., Chan, C. H. F., Walsh, S. A., Wadas, T. J., O’Dorisio, T., O’Dorisio, M. S., Govindan, R., Cliften, P. F., Azhdarinia, A., ... Ear, P. H. (2022). Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy. Cancers, 14(8), 1910. https://doi.org/10.3390/cancers14081910